Global Ophthalmic Viscoelastic Devices (OVDs) Market was valued at $2,341 million in 2020 and is anticipated to grow at $3,227 million by 2027 recording a CAGR of 4.14% during the forecast period 2021-2027. Ophthalmic Viscoelastic Devices (OVDs) Market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments. As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the Ophthalmic Viscoelastic Devices Market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The Ophthalmic Viscoelastic Devices Market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.